Citation Tools
PDFRegular and young investigator award abstracts
Combination immunotherapies
441 Outcomes of patients with metastatic renal cell carcinoma with intermediate- or poor-risk symptomatic disease who received their first cycle of nivolumab and ipilimumab while being hospitalized
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 441 Outcomes of patients with metastatic renal cell carcinoma with intermediate- or poor-risk symptomatic disease who received their first cycle of nivolumab and ipilimumab while being hospitalized